PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
A phase 3 trial testing PM8002 in small-cell lung cancer and non-small-cell lung cancer, active and no longer recruiting.
Overview
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer is a phase 3 interventional study registered as NCT06616532, led by Biotheus, and active but no longer recruiting when checked on 2026-09-11. Official title: A Multicenter, Open-lable, Randomised Phase III Study of PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer. Planned enrolment is 404 participants (estimated). The study started in 2024-11-13 and primary completion is expected in 2027-01-25. No results have been posted on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- TrialPM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
- TrialA Phase IIII Study of AL8326 in Small Cell Lung Cancer
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag ctgov-ingest.
- TrialA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Shares BioNTech and the tag ctgov-ingest.
- TrialA Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag ctgov-ingest.
- TrialA Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
Shares BioNTech and the tag ctgov-ingest.
- TrialSSGJ-707 in Advanced Non-Small Cell Lung Cancer
Shares Non-small-cell lung cancer and the tag ctgov-ingest.
- TrialSymbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shares Non-small-cell lung cancer and the tag ctgov-ingest.
- TrialSymbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Shares Non-small-cell lung cancer and the tag ctgov-ingest.